Sector: Pharmaceuticals & Biotechnology

Large Cap

Zydus Lifesciences Share Price

ZYDUSLIFE

₹1,188.70

38.70(3.37%)

27th Aug 2026 | 3:13 PM

NSE : ZYDUSLIFE

Open Free Demat Account

Zydus Lifesciences Performance

Price Movement

₹1188.70

₹1142.10

₹1195.40

↘ Today's Low↗ Today's High

1 Year Performance

₹1188.70

₹835.50

₹1205.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,195.40

Low₹1,142.10

Open at₹1,160.00

Prev Close₹1,150.00

Volumes31.67 L

Avg Price₹1,171.67

Lower Circuit₹1,153.00

Upper Circuit₹1,224.20

Historical Performance

3M High₹1,205.00

3M Low₹1,048.90

1 Yr High₹1,205.00

1 Yr Low₹835.50

3 Yr High₹1,324.30

3 Yr Low₹567.75

5 Yr High₹1,324.30

5 Yr Low₹319.00

Summary

As of 27-08-2026 15:43, Zydus Lifesciences Ltd. share price today is ₹0, with a change of ₹-1150.00 (-100.00%) from the previous close of ₹1150. The stock opened at ₹1160 and traded between ₹1142.1 and ₹1195.4, with a total traded volume of 3167395 shares. The company has a market capitalization of ₹113151 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹1205 and ₹835.5, respectively.

Zydus Lifesciences Ltd. valuation metrics include a P/E ratio of 25.1, EPS of ₹50.09, and book value of ₹4.00. Profitability indicators show ROE of 18.58% along with a dividend yield of 0.1%. Zydus Lifesciences Ltd. has reported revenue of ₹28591.7 Cr and net profit of ₹4513 Cr.

Zydus Lifesciences Ltd. technical indicators include Day RSI at 49.8, Day MFI at 66.92, Day ADX at 15.69. Additional indicators include Commodity Channel Index (CCI) at -53.9 and Williams %R at -71.62. Momentum indicators show Day MACD at -1.44, Day MACD Signal Line at 2.52, DayATR at 28.45. Rate of Change indicators for Zydus Lifesciences Ltd. include ROC125 at 24.61 and ROC21 at 1.47.

Exponential moving averages include EMA5 at ₹1117.8, EMA10 at ₹1122.8, EMA12 at ₹1124.1, EMA20 at ₹1126.2, EMA26 at ₹1125.6, EMA50 at ₹1110.9, EMA100 at ₹1069.2, EMA200 at ₹1022.6. Simple moving averages include SMA5 at ₹1112.1, SMA10 at ₹1131.5, SMA20 at ₹1129.2, SMA30 at ₹1129.6, SMA50 at ₹1123.6, SMA100 at ₹1053.3, SMA150 at ₹1001.7, SMA200 at ₹982.7.

Support levels for Zydus Lifesciences are placed at First Support ₹1103.07, Second Support ₹1081.63, Third Support ₹1070.67. Resistance levels are seen at First Resistance ₹1135.47, Second Resistance ₹1146.43, Third Resistance ₹1167.87. Zydus Lifesciences Ltd. shareholding pattern shows promoter holding at 75.01%, FII holding at 6.89%, DII holding at 0%, public holding at 6.83%.

Zydus Lifesciences Fundamentals

Market Cap

High in industry

1,13,151 Cr.

PE Ratio (TTM)

Above industry Median

25.10

Dividend Yield

Low in industry

0.10

Net Profit TTM

2% decr over last year

4,513

Net Profit Growth

2% decr over last year

4,513

PEG Ratio

Negative PEG TTM

-16.20

ROE

2% decr over last year

18.58

Operating Revenue TTM

28,591.70

Operating Revenue Growth

21.1% incr over last year

Book Value

Above industry Median

MFI

MFI is mid-range

66.92

RSI

RSI is mid-range

49.80

EPS (TTM)

50.09

Debt to Equity

0.43

Face Value

Operating Profit Margin Qtr.

30.64

Operating Profit Qtr.

1,929.40

Net Profit Qtr.

939.80

Operating Revenue Qtr.

8,017

PB Ratio

Zydus Lifesciences Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Total Revenue	2,872.20	3,740.90	2,283.60	2,871.20	2,588.30
Operating Expense	2,285.20	1,751.80	2,084.60	1,719.30	2,002.90
Operating Profit	587	1,989.10	199	1,151.90	585.40
Depreciation	151.90	150.90	144.30	136	130
Interest	103.10	115.50	116	113.80	137.60
Tax	116.10	389	55.90	287	90.20
Net Profit	339.60	1,722	296.50	1,156.60	384.70

Zydus Lifesciences Technicals

Zydus Lifesciences Ltd. EMA & SMA

₹1188.70

84.90 (7.69%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1117.8

Day EMA10 ₹1122.8

Day EMA12 ₹1124.1

Day EMA20 ₹1126.2

Day EMA26 ₹1125.6

Day EMA50 ₹1110.9

Day EMA100 ₹1069.2

Day EMA200 ₹1022.6

Zydus Lifesciences Support and Resistance

Resistance

First Resistance₹1135.47

Second Resistance₹1146.43

Third Resistance₹1167.87

Support

First Support₹1103.07

Second Support₹1081.63

Third Support₹1070.67

Technical Indicators

Day RSI49.80

Day MFI66.92

Day ADX15.69

Day Commodity Channel Index-53.90

William-71.62

Day MACD-1.44

Day MACD Signal Line2.52

Day ATR28.45

Day ROC12524.61

Day ROC211.47

Zydus Lifesciences Shareholding Pattern

Held By	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoter	75	75	75	75	75	75
FII	7.3	7.1	7.3	7.1	7	6.9
DII	11	11.2	10.9	11	11.2	11.3
Public	6.7	6.7	6.8	6.9	6.9	6.8

Zydus Lifesciences Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	5.91 L	11.93 L	49.51%
Week	5.97 L	11.19 L	53.35%
1 Month	7.38 L	15.96 L	46.22%
6 Month	6.52 L	14.12 L	46.15%

Zydus Lifesciences SWOT Analysis

Strengths12

Weakness6

Opportunity9

Threats3

Benjamin Graham Value Screen

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Companies with Low Debt

Increasing Revenue every quarter for the past 3 quarters

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Top Gainers

Stocks near 52 Week High with Significant Volumes

Zydus Lifesciences Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
24 Jul, 2026	1	FINAL	24 Jul, 2026	Equity Share
25 Jul, 2025	11	FINAL	25 Jul, 2025	Equity Share
26 Jul, 2024	3	FINAL	26 Jul, 2024	Equity Share
28 Jul, 2023	6	FINAL	28 Jul, 2023	Equity Share
28 Jul, 2022	2.5	FINAL	29 Jul, 2022	Equity Share
28 Jul, 2021	3.5	FINAL		Equity Share
23 Mar, 2020	3.5	INTERIM	24 Mar, 2020	Equity Share
25 Jul, 2019	3.5	FINAL		Equity Share
31 Jul, 2018	3.5	FINAL		Equity Share
16 Mar, 2017	3.2	INTERIM	17 Mar, 2017	Equity Share

Zydus Lifesciences Stock Comparison

Financials	Rubicon Research Ltd.	Anthem Biosciences Ltd.	Sai Life Science Ltd.	Emcure Pharmaceuticals Ltd.	Mankind Pharma Ltd.	Piramal Pharma Ltd.
Price (₹)	₹1,844	₹928.10	₹1,487.90	₹1,875.50	₹2,390.80	₹215
% Change	1.39%	0.55%	1.84%	0.71%	-0.12%	1.76%
Revenue TTM (₹ Cr)	₹1,935.80	₹2,002.34	₹2,250.36	₹9,683.45	₹14,737.88	₹9,205.28
Net Profit TTM (₹ Cr)	₹288.22	₹575.94	₹361.74	₹1,011.39	₹2,042.67	₹-313.62
PE TTM	98.10	85.50	85.40	34.60	47.80	-88.20
1 Year Return	252.33	3.68	60.48	23.65	-7.51	7.72
ROCE	24.32	27.56	18.38	25.65	14.32	2.29

Similar Stocks

ACUTAAS

Acutaas Chemicals Ltd.

₹ 3335.10

+2.37%

GLAND

Gland Pharma Ltd.

₹ 2873.90

-1.01%

LAURUSLABS

Laurus Labs Ltd.

₹ 1927.10

+2.13%

ALKEM

Alkem Laboratories Ltd.

₹ 5344.50

+0.77%

BIOCON

Biocon Ltd.

₹ 415.80

-0.41%

DIVISLAB

Divi's Laboratories Ltd.

₹ 9093.00

+0.75%

GRANULES

Granules India Ltd.

₹ 832.80

+0.56%

AJANTPHARM

Ajanta Pharma Ltd.

₹ 3540.20

-0.33%

GLENMARK

Glenmark Pharmaceuticals Ltd.

₹ 2453.00

+0.60%

WOCKPHARMA

Wockhardt Ltd.

₹ 1961.00

+4.19%

AUROPHARMA

Aurobindo Pharma Ltd.

₹ 1623.10

+0.01%

SUNPHARMA

Sun Pharmaceutical Industries Ltd.

₹ 1910.50

+0.58%

NEULANDLAB

Neuland Laboratories Ltd.

₹ 23429.00

-0.49%

IPCALAB

Ipca Laboratories Ltd.

₹ 1959.00

+0.34%

GLAXO

GlaxoSmithKline Pharmaceuticals Ltd.

₹ 3066.90

+1.07%

PFIZER

Pfizer Ltd.

₹ 4738.40

-1.33%

ABBOTINDIA

Abbott India Ltd.

₹ 26325.00

-0.87%

TORNTPHARM

Torrent Pharmaceuticals Ltd.

₹ 4970.00

+1.64%

LUPIN

Lupin Ltd.

₹ 2168.00

-0.78%

DRREDDY

Dr. Reddy's Laboratories Ltd.

₹ 1176.00

-0.51%

CIPLA

Cipla Ltd.

₹ 1415.00

+0.88%

FAQ's on ZYDUSLIFE

What is the current share price of Zydus Lifesciences Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Zydus Lifesciences Ltd. is ₹ 1188.7 on the NSE and ₹ 1185.4 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Zydus Lifesciences Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Zydus Lifesciences Ltd. is approximately ₹ 113151 Cr.

What are the PE and PB ratios for Zydus Lifesciences Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Zydus Lifesciences Ltd. is 25.1, and the Price-to-Book (PB) ratio is 4.

What is the 52-Week High and Low for Zydus Lifesciences Ltd.?

Over the past 52 weeks, the highest price reached by Zydus Lifesciences Ltd. shares was ₹ 1205, and the lowest price was ₹ 835.5.

What is the current dividend yield for Zydus Lifesciences Ltd.?

As of 6 June 2025, the dividend yield for Zydus Lifesciences Ltd. is 0.1%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Zydus Lifesciences Ltd.?

Significant shareholdings in Zydus Lifesciences Ltd. typically include entities such as:

Promoter
FII
Public
Other Institutions
Mutual Funds

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Zydus Lifesciences Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Zydus Lifesciences Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Zydus Lifesciences Ltd.?

Zydus Lifesciences Ltd. last declared a FINAL dividend of ₹ 1 per share for the financial period ending 2026. The record date was set as 2026-07-24, and the payment was/is scheduled around 2026-07-24. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy